Engineering the Future of Longevity R&D: The Case for AI-Driven, Integrated Biotechnology Ecosystems.

The escalating cost, extended timelines, and low success rates in pharmaceutical research demand a rethinking of biotechnology R&D infrastructure to more efficiently discover and deliver novel therapeutics to an increasingly aging population. We intr…

Preview only. Read the full abstract at the source